Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Int Arch Allergy Immunol ; 173(1): 12-22, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28486236

RESUMEN

BACKGROUND: Allergic sensitization might be influenced by the lipids present in allergens, which can be recognized by natural killer T (NKT) cells on antigen-presenting cells (APCs). The aim of this study was to analyze the effect of olive pollen lipids in human APCs, including monocytes as well as monocyte-derived macrophages (Mϕ) and dendritic cells (DCs). METHODS: Lipids were extracted from olive (Olea europaea) pollen grains. Invariant (i)NKT cells, monocytes, Mϕ, and DCs were obtained from buffy coats of healthy blood donors, and their cell phenotype was determined by flow cytometry. iNKT cytotoxicity was measured using a lactate dehydrogenase assay. Gene expression of CD1A and CD1D was performed by RT-PCR, and the production of IL-6, IL-10, IL-12, and TNF-α cytokines by monocytes, Mϕ, and DCs was measured by ELISA. RESULTS: Our results showed that monocytes and monocyte-derived Mϕ treated with olive pollen lipids strongly activate iNKT cells. We observed several phenotypic modifications in the APCs upon exposure to pollen-derived lipids. Both Mϕ and monocytes treated with olive pollen lipids showed an increase in CD1D gene expression, whereas upregulation of cell surface CD1d protein occurred only in Mϕ. Furthermore, DCs differentiated in the presence of human serum enhance their surface CD1d expression when exposed to olive pollen lipids. Finally, olive pollen lipids were able to stimulate the production of IL-6 but downregulated the production of lipopolysaccharide- induced IL-10 by Mϕ. CONCLUSIONS: Olive pollen lipids alter the phenotype of monocytes, Mϕ, and DCs, resulting in the activation of NKT cells, which have the potential to influence allergic immune responses.


Asunto(s)
Alérgenos/inmunología , Células Presentadoras de Antígenos/inmunología , Lípidos/inmunología , Células T Asesinas Naturales/inmunología , Olea/inmunología , Polen/inmunología , Antígenos CD1d/inmunología , Citocinas/inmunología , Humanos
3.
Am J Physiol Gastrointest Liver Physiol ; 302(7): G645-54, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22207581

RESUMEN

Eosinophilic esophagitis (EoE) is a recently recognized inflammatory disorder driven by food hypersensitivity; however, the specific foods and mechanisms involved are unclear. In patients with EoE, we have found that hypersensitivities to corn and peanuts are the most common. Accordingly, we sensitized and exposed mice either intranasally or intragastrically with corn or peanut extract or saline. Esophageal eosinophilia, the genes of eosinophil-directed cytokines, and allergen-induced antibodies were examined in mice challenged with corn or peanut extract or saline. A high number of esophageal lamina propria eosinophils as well as eosinophilic microabscesses, intraepithelial eosinophils, extracellular eosinophilic granules, thickened and disrupted epithelial mucosa, and mast cell hyperplasia were observed in the esophagus of peanut or corn allergen-challenged mice. Mechanistic analysis indicated that para-esophageal lymph nodes might be critical in the trafficking of eosinophils to the esophagus and in EoE association to airway eosinophilia. Furthermore, experimentation with gene-targeted mice revealed that peanut allergen-induced EoE was dependent on eotaxin and invariant natural killer T (iNKT) cells, as CD1d and eotaxin-1/2 gene-deficient mice were protected from disease induction. Thus we provide evidence that para-esophageal lymph nodes are involved in food- or aeroallergen-induced eosinophilia and patchy EoE pathogenesis, likely a mechanism dependent on eotaxins and iNKT cells.


Asunto(s)
Esofagitis Eosinofílica/inmunología , Hipersensibilidad a los Alimentos/inmunología , Ganglios Linfáticos/fisiología , Células T Asesinas Naturales/fisiología , Animales , Antígenos CD1d/genética , Antígenos CD1d/inmunología , Arachis/inmunología , Aspergillus , Quimiocina CCL11/genética , Quimiocina CCL11/inmunología , Quimiocina CCL24/genética , Quimiocina CCL24/inmunología , Esofagitis Eosinofílica/etiología , Esofagitis Eosinofílica/patología , Esófago/inmunología , Esófago/patología , Femenino , Hipersensibilidad a los Alimentos/complicaciones , Inmunoglobulina E/metabolismo , Exposición por Inhalación , Ganglios Linfáticos/inmunología , Masculino , Mastocitos/citología , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales/administración & dosificación , Extractos Vegetales/inmunología , Organismos Libres de Patógenos Específicos , Zea mays/inmunología
4.
Dig Dis Sci ; 55(9): 2514-9, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19949865

RESUMEN

PURPOSE: Tacrolimus is a potent immunomodulator that is effective in the treatment of inflammatory bowel disease (IBD). However, potential toxicity and systemic effects with oral intake limit its use. Local tacrolimus treatment is effective in a subgroup of proctitis patients. This study aimed to evaluate whether colonic mucosal immune cells are susceptible to locally applied tacrolimus in vitro. Our in vivo studies aimed at evaluating whether local tacrolimus treatment in mice would bring about local immune suppression and to compare colonic and systemic tacrolimus levels after locally and systemically applied tacrolimus. RESULTS: In vitro tacrolimus inhibited the activation of multiple cell types present in colonic tissue; lamina propria T cells, NKT cells, and both classical- and non- classical antigen presenting cells. However, the cytokine production of epithelial cells was not inhibited by tacrolimus at these concentrations. After rectal administration in mice, tacrolimus blood levels were comparable to those obtained by oral intake. However, rectally treated mice exhibited a 14-fold higher concentration of tacrolimus within their colonic tissue than orally treated mice. Moreover, rectally applied tacrolimus resulted in a local but not a systemic immune suppression in mice. CONCLUSIONS: Tacrolimus inhibits activation of several pivotal immune cells of the intestinal mucosa. Murine studies indicate that colonic application of tacrolimus induces local rather than systemic immune suppression.


Asunto(s)
Colon/efectos de los fármacos , Fármacos Gastrointestinales/farmacología , Inmunidad Mucosa/efectos de los fármacos , Inmunosupresores/farmacología , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Mucosa Intestinal/efectos de los fármacos , Tacrolimus/farmacología , Administración Oral , Administración Rectal , Animales , Células Presentadoras de Antígenos/efectos de los fármacos , Células Presentadoras de Antígenos/inmunología , Antígenos CD1d/inmunología , Células CACO-2 , Técnicas de Cocultivo , Colon/inmunología , Relación Dosis-Respuesta a Droga , Enema , Fármacos Gastrointestinales/administración & dosificación , Fármacos Gastrointestinales/sangre , Fármacos Gastrointestinales/farmacocinética , Humanos , Inmunosupresores/administración & dosificación , Inmunosupresores/sangre , Inmunosupresores/farmacocinética , Enfermedades Inflamatorias del Intestino/inmunología , Mucosa Intestinal/inmunología , Ratones , Ratones Endogámicos BALB C , Células T Asesinas Naturales/efectos de los fármacos , Células T Asesinas Naturales/inmunología , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Tacrolimus/administración & dosificación , Tacrolimus/sangre , Tacrolimus/farmacocinética
5.
Blood ; 113(11): 2498-507, 2009 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-19056691

RESUMEN

Down-regulation of conventional human leukocyte antigen (HLA) class I and II molecules from the surface of tumor cells is an important mechanism for tumor immune evasion, survival, and progression. Whether CD1d, a nonconventional, glycolipid-presenting HLA class I-like molecule instructing the function of the immunoregulatory invariant NKT cells can affect tumor cell survival is not known. Here we show that CD1d is highly expressed in premalignant and early myeloma, but with disease progression its expression is reduced and eventually in advanced stages and myeloma cell lines is lost altogether, suggesting that CD1d impacts negatively on myeloma cell survival. Consistent with this, engagement of CD1d by anti-CD1d monoclonal antibodies (mAbs) induces cell death of myeloma cell lines with restored CD1d expression and primary myeloma cells. Cell death induced by monoclonal antibody engagement of CD1d is associated with overexpression of proapoptotic Bax and mitochondrial membrane potential loss but it is caspase-activation independent; in addition, it requires the cytoplasmic tail but not the Tyr residue critical for lysosomal sorting of CD1d. Finally, anti-CD1d cooperates with antimyeloma agents in the killing of myeloma cells. Thus, this work provides evidence linking a novel function of CD1d in the regulation of cell death with tumor survival and progression in humans.


Asunto(s)
Anticuerpos Monoclonales/farmacología , Antígenos CD1d/fisiología , Mieloma Múltiple/genética , Mieloma Múltiple/patología , Anticuerpos Monoclonales/administración & dosificación , Antígenos CD1d/genética , Antígenos CD1d/inmunología , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Apoptosis/efectos de los fármacos , Linfocitos B/efectos de los fármacos , Linfocitos B/metabolismo , Ácidos Borónicos/administración & dosificación , Bortezomib , Agregación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/genética , Dexametasona/administración & dosificación , Progresión de la Enfermedad , Evaluación Preclínica de Medicamentos , Regulación Neoplásica de la Expresión Génica , Humanos , Mieloma Múltiple/tratamiento farmacológico , Mieloma Múltiple/metabolismo , Células Plasmáticas/efectos de los fármacos , Células Plasmáticas/metabolismo , Pirazinas/administración & dosificación , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA